Company news
ANI Pharmaceuticals, Inc. news in 2020
ANI Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets
December 16, 2020
ANI Pharmaceuticals Reports Third Quarter 2020 Results
November 4, 2020
ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial Results
October 28, 2020
ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 9, 2020
ANI Pharmaceuticals Reports Second Quarter 2020 Results
August 5, 2020
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio “Tony” Pera to Board of Directors
August 5, 2020
ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer
August 2, 2020
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results
July 29, 2020
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets
July 5, 2020
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
June 29, 2020
ANI Pharmaceuticals Provides Update on Recent Regulatory Filing
May 31, 2020
ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO
May 6, 2020
ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2020 Financial Results
April 29, 2020
ANI Receives Refusal to File Letter from FDA for Cortrophin® Gel
April 28, 2020
ANI Announces Upcoming Departure of CEO
April 13, 2020
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL
April 12, 2020
ANI Pharmaceuticals Announces Launch of Omega-3-Acid Ethyl Esters Capsules USP
April 1, 2020
ANI Announces Launch of Polyethylene Glycol 3350, 17g/Packet
March 25, 2020
ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL
March 23, 2020
ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
March 1, 2020
ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020
February 26, 2020
ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2019 Financial Results
February 19, 2020
ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL
February 11, 2020
ANI Announces Launch of Tolterodine Extended-Release Capsules
January 23, 2020
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
January 15, 2020
ANI Announces Launch of Paliperidone Extended-Release Tablets
January 13, 2020
ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.
January 8, 2020